The Haselmeier Pen 8 is a hand-held mechanical device intended for subcutaneous self administration of FDA-approved drugs and biologics. The Haselmeier Pen 8 is designed to be used with 3.0 mL cartridges which are prefilled prior to injection. The Haselmeier Pen 8 is for use in the home environment to aid and support prescribed treatment and therapy.
Device Story
Haselmeier Pen 8 is a reusable, hand-held mechanical pen-injector; used for subcutaneous injection of medication. Input: 3.0-mL prefilled medication cartridge; detachable, single-use hypodermic needle. Operation: User dials desired dose (0.08 mL); mechanical delivery of medication. Used in home environment or clinical settings; operated by patients or healthcare professionals. Output: Subcutaneous delivery of prescribed drug/biologic. Benefit: Facilitates accurate, patient-administered subcutaneous therapy.
Clinical Evidence
Bench testing only. Device performance demonstrated via conformance to ISO 11608-1:2000 (Pen-injectors for Medical Use - Part 1: Requirements and Test Methods).
Technological Characteristics
Reusable mechanical pen-injector; 3.0-mL cartridge capacity; compatible with ISO 11608-2:2000 needles and ISO 11608-3:2000 3-mL type A cartridges. Manual dose setting mechanism. No electronic components or software.
Indications for Use
Indicated for subcutaneous self-administration of FDA-approved drugs and biologics in home environments by patients or health professionals using 3.0 mL prefilled cartridges.
Regulatory Classification
Identification
A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.
{0}------------------------------------------------
Special 510(k) Premarket Notification Haselmeier GmbH
#### CONFIDENTIAL
510(k) Summary
SEP 2 6 2008
Page 1 of 2
# 510(k) SUMMARY
[as required by section 807.92(c)]
### General Information
| Submitted by: | Haselmeier GmbH<br>Dufourstr. 32<br>CH-8008 Zurich<br>Switzerland |
|-----------------|---------------------------------------------------------------------------------|
| Contact Person: | Robert J. Kilgore |
| | Haselmeier USA<br>517 Benfield Road<br>Suite 301<br>Severna Park, MD 21146-2596 |
| | Phone: 410 647-7300<br>Fax: 410 647-7383<br>Email: r.kilgore@haselmeier.com |
| Date Prepared: | September 4, 2008 |
| Device Name | |
#### Trade Name: Haselmeier Pen 8 Common Name: Piston syringe
# Predicate Devices
Haselmeier Pen
K070100
Haselmeier Sàrl
# Device Description
The Haselmeier Pen 8 is a reusable pen-injector designed to provide a method of accurately subcutaneously injecting the desired dose of medication from single lumen hypodermic needle. The device can be used by health professionals or for selfinjection by the patient.
The pen-injector uses 3.0-mL cartridges of medication and a single use, detachable and disposable needle (supplied separately). The pen injector allows the user to dial the desired dose (0.08 mL).
The device is compatible with commercially available pen needles (supplied separately) that comply with: ISO 11608-2:2000 Pen-injectors for medical use PPart
{1}------------------------------------------------
Special 510(k) Premarket Notification Haselmeier GmbH CONFIDENTIAL 510(k) Summary Page 2 of2
2: Needles - Requirements and test method and 3-mL ISO type A cartridges (supplied separately), which meet ISO 11608-3: 2000 Pen-injectors for medical use Part 3: Finished cartridges - Requirements and test methods, with the following dimensions:
Overall cartridge length including aluminum cap: 63.9 mm+/- 0.3 mm Outside Cartridge Diameter: 11.94 mm MAX. Inner Cartridge Diameter: 9.65 mm +/- 0.1 mm measured at open end. Maximum eccentricity of aluminum cap: 0.33 mm
# Intended Use
The Haselmeier Pen 8 is a hand-held mechanical device intended for subcutaneous self administration of FDA-approved drugs and biologics. The Haselmeier Pen 8 is designed to be used with 3.0 mL cartridges which are prefilled prior to injection. The Haselmeier Pen 8 is for use in the home environment to aid and support prescribed treatment and therapy.
# Technological Comparison
The Haselmeier Pen 8 has similar indications for use and overall function and performs in a similar manner with respect to the Haselmeier Pen 60.
The technological characteristics of the Haselmeier Pen 8 and its drug cartridge are the same as product currently legally marketed in the USA.
#### Performance Data
The Haselmeier Pen 8 has been demonstrated to perform as intended. The Haselmeier Pen 8 conforms to the requirements when the methods specified in the ISO Standard, ISO 11 608- 1:2000, "Pen-injectors for Medical Use _ Part 1 Requirements and Test Methods."
#### Conclusion
Haselmeier concludes based on the information presented that the Haselmeier Pen 8 is substantially equivalent to products currently, legally marketed in the USA.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle-like symbol with three curved lines representing wings or feathers. The symbol is positioned to the right of the text, which reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement around the symbol. The text is in all caps and is smaller than the symbol.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
# SEP 2 6 2008
Haselmeier GmbH C/O Mr. Stephen J. Goldner President Regulatory Affairs Associates, Incorporated 30833 Northwestern Highway, Suite 121 Farmington, Michigan 48334-2581
Re: K082616
Trade/Device Name: Haselmeier Pen 8 Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: II Product Code: FMF Dated: September 5, 2008 Received: September 9, 2008
Dear Mr. Goldner:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
#### Page 2 - Mr. Goldner
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
*Khamuel's Lindmy focy*
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
{4}------------------------------------------------
Special 510(k) Premarket Notification Haselmeier GmbH
CONFIDENTIAL
Indications for Use
Page 1 of 1
# INDICATIONS FOR USE
510(k) Number (if known):
Device Name:
Haselmeier Pen 8
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Sponsor Name:
Haselmeier GmbH
Indications for Use:
The Haselmeier Pen 8 is a hand-held mechanical device intended for subcutaneous selfadministration of FDA-approved drugs and biologics. The Haselmeier Pen 8 is designed to be used with 3.0 mL cartridges which are prefilled prior to injection. The Haselmeier Pen 8 is for use in the home environment to aid and support prescribed treatment and therapy.
Prescription Use X (21 CFR 801 Subpart D) Or
Over-The-Counter Use (21 CFR 807 Subpart C)
Do Not Write Below This Line - Continue on Another Page if Needed
Concurrence of CDRH, Office of Device Evaluation (ODE)
Gromm
Division Sign-Off) Jivision of Anesthesiology, General Hospital ויו
i10(k) Number: _ 大482616
ﻜﺴ
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.